Proton Therapy Improves Survival and Reduces Side Effects in Patients Treated for Head and Neck Cancer
Multi-institutional study published in The Lancet reports results from the largest randomized Phase III trial to date comparing protons and IMRT
JACKSONVILLE, Fla. (January 8, 2026) – A new clinical research article published last month in The Lancet says patients with head and neck cancer treated with proton therapy may have better survival and quality of life outcomes compared to people treated with IMRT.